About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials | 527 Studies Recruiting

Clinical TrialsDiabetes

Diabetes Clinical Trials

Browse 527 clinical trials for diabetes. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 527 trials

CompletedUser Experience With DuraTouch® in Patients With Type 1 or Type 2 DiabetesThis study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study…NCT07052292·Wroclaw, Kuyavian-Pomeranian Voivodeship and 10 others UnknownEvaluation and Comparison of Noninvasive Blood Glucose ConcentrationsComparison of noninvasive glucose measurement performance versus standard invasive reference measurements.NCT01745900·San Diego, California CompletedComparison of Three Lancing Devices Regarding Capillary Blood Volume and Lancing Pain Intensity.A randomized single-blind study with the use of three lancing devices equipped with personal lancets.NCT03479619·Lodz CompletedSingle Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)This is an active- and placebo-controlled, single-site, four-part trial of MK-1092 in healthy adult participants, in participants with type 1 diabetes mellitus (T1DM), and in…NCT03170544·Chula Vista, California

Related Searches

type 2 diabetestrials type 1 diabetestrials t2dtrials t1dtrials

Data from ClinicalTrials.govTerms

CompletedSpecial Survey of Production of Insulin Aspart Specific AntibodyThis study is conducted in Japan. The aim of this study is to collect data of production of insulin aspart specific antibody under normal clinical practice conditions.NCT01487369·Tokyo

CompletedStudy of Insulin Pump Discontinuation in Adults With DiabetesThe purpose of this study is to determine the rate of insulin pump discontinuation 18 months after initiation in patients with diabetes, and to determine factors associated with…NCT04915066·Corbeil-Essonnes

CompletedEvaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).Recent advances in continuous glucose monitors (CGMs) and availability of commercial CGM products to patients with type 1 and type 2 diabetes has made the use of CGM more…NCT04094064·Charlottesville, Virginia

CompletedImplementing Continuous Glucose Monitoring in Primary Care for Patients With DiabetesThe overarching goal of this study is to decrease disparities and increase access to continuous glucose monitoring (CGM) for patients with diabetes, regardless of where people…NCT05336214·Aurora, Colorado

WithdrawnGLUCOME USABILITY STUDYThe GlucoMe device, in its original packaging, along with the user manual and QuickStart guide will be provided to the patient in a simulated home use environment.NCT02488278

TerminatedAn Audit of the Impact of Tailored Information Delivered Via a Digital Learning PlatformThe study intends to audit the impact of optimal insulin injection technique on clinical parameters and self-care behaviour of insulin treated diabetes patients in a prospective…NCT04007003·Antwerp and 8 others

Active not recruitingThe Hong Kong Diabetes BiobankAsia is in the midst of an epidemic of diabetes.NCT05282680·Shatin

CompletedEuropean, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.Accu-Chek® Insight Insulin Pump EU Study is a Multicenter Study to evaluate the Accu-Chek® Insight Insulin Pump in routine practice.NCT02105103·Graz and 7 others

CompletedClosed Loop Glucose Control in Patients With Type 1 and Type 2 DiabetesThis is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting.NCT05644730·Atlanta, Georgia

UnknownEnhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced FeaturesA Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features.NCT05131139·Escondido, California and 3 others

CompletedThe Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 DiabetesEndocrine hormones, not only blood glucose responsive hormones, but also sexual hormones, thyroid hormones, growth hormones and so on, may have response and activites in…NCT05290207·Nanjing

CompletedTurkish Version of The Diabetes Quality of Life Brief Clinical Inventory Validity and ReliabilityThis study aims to develop Turkish version of the Diabetes Quality of Life Brief Clinical Inventory (DQL-BCI) and to perform validity and reliability evaluations.NCT05407454·Bitlis

CompletedAn Online, Compassion Intervention for Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM).The goal of this research study is to evaluate a programme that is based on Compassionate Mind Training (CMT) over four-weeks.NCT05749029·Royal Tunbridge Wells, Tunbridge Wells

CompletedEvaluation of the Accuracy of an Implanted Glucose SensorThe purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared…NCT02647905·Concord, California and 8 others

CompletedTo Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.Patients will be enrolled and randomly assigned to either the test group or the control group for short-time intensive insulin therapy in inpatient setting.NCT07403565·Beijing, Beijing Municipality and 4 others

Not yet recruitingArgus 2.0 Adoption StudyThis study evaluates the usability of the KOS Argus Continuous Glucose Monitoring (CGM) System, a noninvasive, wrist-worn device that estimates blood glucose levels using…NCT07425236·San Mateo, California

PreviousPage 9 of 27Next